SCHEMBL25529090

SCHEMBL25529090

C[C@@H]1C(=O)N(C)c2cc(-c3ccncc3)ccc2C(=O)N1Cc1cc(F)cc(C(=O)NCC2CC(OC(=O)CN3CCCCC3)C2)c1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.33
ROCK1 Q13464 2/20 0.33
CACNA1H O95180 2/20 0.33
CACNA1G O43497 5/20 0.32
DYRK1A Q13627 2/20 0.32
WNT1 P04628 1/20 0.32
GAA P10253 2/20 0.31
LMNA P02545 1/20 0.31
AURKA O14965 1/20 0.30
USP30 Q70CQ3 1/20 0.30
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
SCN9A Q15858 1/20 0.30
CACNA1I Q9P0X4 1/20 0.30
KCNH2 Q12809 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25529168 0.91 HRH3 (0.35) ROCK2ROCK1CACNA1HCACNA1GUSP30
SCHEMBL25531296 0.91 ROCK2 (0.33) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25531285 0.91 ROCK2 (0.33) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25529072 0.88 CACNA1H (0.34) ROCK2ROCK1CACNA1HCACNA1GAURKA
SCHEMBL25532518 0.88 CACNA1H (0.36) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25528922 0.88 CACNA1H (0.35) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25528945 0.88 CACNA1H (0.36) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25528621 0.88 CACNA1H (0.36) ROCK2ROCK1CACNA1HAURKAUSP30
SCHEMBL25528924 0.87 CACNA1H (0.37) ROCK2ROCK1CACNA1HGAAAURKA
SCHEMBL25528475 0.86 CACNA1H (0.36) ROCK2ROCK1CACNA1HAURKAUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed